002317.SZ Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (8 geg. 2024 @ 10:04):

Guangdong Zhongsheng Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. The company offers Chinese and chemical medicines...

Stats
Dzisiejszy wolumen	17.94M
Średni wolumen	32.67M
Kapitalizacja rynkowa	12.65B
EPS	CNY0.0823 ( 2023-10-30 )
Następna data zysków	( CNY0 ) 2024-05-14
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	72.14
ATR14	CNY0.0150 (0.10%)

Wolumen Korelacja

Długi: -0.24 (neutral)

Krótki: -0.40 (neutral)

Signal:(31.743) Neutral

Guangdong Zhongsheng Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Guangdong Zhongsheng Korelacja - Waluta/Towar

0.17
( neutral )

0.18
( neutral )

0.00
( neutral )

-0.54
( weak negative )

0.41
( neutral )

0.24
( neutral )

Guangdong Zhongsheng Finanse

Annual	2023
Przychody:	CNY2.61B
Zysk brutto:	CNY1.53B (58.60 %)
EPS:	CNY0.320

FY	2023
Przychody:	CNY2.61B
Zysk brutto:	CNY1.53B (58.60 %)
EPS:	CNY0.320

FY	2022
Przychody:	CNY2.68B
Zysk brutto:	CNY1.74B (64.86 %)
EPS:	CNY0.400

FY	2021
Przychody:	CNY2.43B
Zysk brutto:	CNY1.62B (66.80 %)
EPS:	CNY0.350

Financial Reports:

No articles found.

Guangdong Zhongsheng

Guangdong Zhongsheng Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. The company offers Chinese and chemical medicines. It is also involved in the research and development of products in the fields of ophthalmology, cardiovascular, cerebrovascular, respiratory, digestive, diabetes, tumor, and senile degenerative diseases. The company was founded in 1979 and is based in Dongguan, China.